ABSTRACT
INTRODUCTION
The effectiveness of the arsenal of antibiotics now in use, including methicillin, is decreasing in the face of emerging bacterial resistance and has been the subject of various reviews and research. During the last two decades, new infectious diseases have appeared e.g Ebola and Buruli ulcer, and some old ones previously thought to be controlled e.g gonorrhoea, have re-emerged (Casell and Mekalonos, 2001) . Furthermore, the usefulness of existing antimicrobial agents is rapidly fading, tipping the balance in favour of multidrug resistant pathogens, including MRSA, and there appears to be few, if any, new classes of drugs currently in use to fight against the multidrug resistant pathogens. Multidrug-resistance (MDR) exhibited by many bacterial species is a major problem in treating both hospital and community acquired infections. Many strains of MRSA possess efflux pumps such as the specific TetK and MsrA transporters which export or extrude certain tetracyclines and macrolides, and the multidrug resistance proteins NorA and QacA which confer resistance to a wide range of structurally unrelated antibiotics (Koyama, 2006) . The inhibition of efflux pumps or mechanism in a bacterial cell could therefore be a means of reversing resistance.
A bacterial resistance modifying agent therefore, reduces the minimum inhibitory concentration (MIC) for an antibiotic to which resistance has already occurred. This could be of great benefit in combinatory therapy, perhaps facilitating the reintroduction of antibiotics that are no longer effective due to resistance (Gibbons, 2005 ). An example of synergistic combination in commercial antibacterial chemotherapy in the treatment of various infections is Augmentin TM , comprising β-lactamase inhibitor, clavulanic acid with amoxicillin. As part of an ongoing study, the antibacterial activity of Paullinia pinnata L. against three resistant strains of Staphylococcus aureus; SA1199B, RN4220, XU212 had been assessed by Annan et al. (2005) . We here report the effect of the isolates from the methanolic extract on the resistant Staphylococcus strains and also in combination with standard antibiotics tetracycline, erythromycin and norfloxacin respectively. These were tested against the bacteria strains to which they are resistant.
MATERIALS AND METHODS

Plant materials
Plant materials were collected in June 2005 and authenticated at the Centre for Scientific Research into Plant Medicine (CSRPM), AkwapimMampong, Ghana, where voucher specimen 13/05/013 has been deposited.
Preparation of extracts 50 gm of the dried powdered roots was packed into a cellulose thimble (28x100 mm) and soxhlet -extracted with 400ml methanol (Sigma) over 48 hours until the material was exhausted. The extract was concentrated under reduced pressure using the rotary evaporator and dried over nitrogen to give a yield of 3.21gm.
Isolation of compounds
Column chromatography was used to isolate compounds from the active chloroform fraction. 2.0gm of material was packed over 150g silica gel [(0.040-0.060mm) 230-400 mesh ASTM] using the wet method. Gradient elution was employed, starting with 1% ethyl acetate in petroleum ether o C) and ending with 100% ethyl acetate. 30 x 200ml aliquots were collected (1-30) and concentrated under reduced pressure. Based upon the TLC (thin layer chromatography) analysis of the thirty different aliquots, 1-4 were bulked and further purified to yield 1 (24.3mg). Aliquots 5-9 were bulked and further crystallized in chloroform to yield 2 (33.4mg). Aliquots 10-13 were bulked, subjected to further column chromatography to yield 3 (425mg). Aliquots 16-30 were bulked, subjected to further column chromatography and crystallized out of methanol as 4 (45.6mg).
General methods
The NMR (both 1 H and 13 C) spectra were determined with the assistance of the Chemistry Department, King's College, London.
1 H and 13 C-NMR were recorded on a Bruker DPX 600 spectrometer (ppm, J in Hz) using TMS as internal standard. DEPT and 2D-NMR experiments were also carried out on the same instrument.
Bacteria used
The resistant bacteria used for the tests were a kind donation from Prof. Simon Gibbons of Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy, University of London and included resistant strains of Staphylococcus aureus SA1199B, RN4220, XU212.
Antibacterial assay
Inocula of the bacteria were prepared from the 24 h Mueller-Hinton broth (Sigma) cultures and suspensions were adjusted to 10 5 CFU/ml. Isolates were dissolved in 2% dimethylsulphoxide (DMSO) . MIC values of the isolates were determined based on a micro-well dilution method (Eloff, 1998) . The 96-well sterile plates were pre-pared by dispensing 180 µl of the inoculated broth plus a 20 µl aliquot of the isolate made up in broth or 20 µl broth in the case of negative control in each well. Tetracycline (Sigma) was included as positive control. Plates were incubated for 24 h at 37 o C. Bacterial growth was determined after addition of 50µl p-iodonitrotetrazolium blue (0.2 mg/ml, Sigma).
Bacterial resistance modulation assay
The modulation assay was performed using 10µg/ ml of the isolated compounds to find the effect of combining them with standard antibiotics norfloxacin, tetracycline and erythromycin on resistant strains of Staph. aureus SA1199B (NorA), XU212 (tetK) and RN4220 (MsrA) respectively following the method of Oluwatuyi et al. (2004) . 100µl of Muller Hinton Broth (MHB) was placed in each well except wells in column 1. 200µl of antibiotic was placed in wells of column 1 and serially diluted 2-fold to give a dilution range 512 -1µg/ml. To the wells in first three rows were added 100µl of the compound (made so as to bring the net concentration in each well to 10µg/ ml) except those in columns 11 and 12. To the wells in rows four to six were added 100µl of reserpine (solution made so as to bring the net concentration in well to 10µg/ml). Wells in rows seven and eight were however, maintained free from both the isolate and reserpine. Wells in columns 11 and 12 were used as general and sterile controls respectively. Plates were incubated at 37 o C for 24 hours, after which 20µl of MTT was added to each well and incubated for further 30 minutes. Inhibition of bacterial growth was visible as a clear well and the presence of growth detected by the presence of a blue colour in the well. All experiments were performed in triplicate under aseptic conditions. (Kovganko et al., 1999) . The unequivocal identification of [2] was confirmed by direct TLC comparison with the reference commercial β-sitosterol (Sigma-Aldrich, USA, batch number 47C-0262). Co-chromatography of [2] and the reference sample gave identical R f values and chromogenic reaction to spray reagents. β-sitosterol has been isolated from numerous species and different families, including the leaves of P. pinnata (Miemanang et al., 2006 (Kovganko et al., 1999) . The chemical shifts of carbon atoms in rings B, C and D and the side chains of [3] and β-sitosterol [2], were identical. The differences in the chemical shifts of the atoms in ring A were as a result of the conversion of OH, attached to C-3 in β-sitosterol, to the acetate. Thus the signal for C-3 in the spectrum of the acetate shifted to downfield by ~2 ppm owing to the α-effect of the acetoxy group, compared with its position in the spectrum of OH in β-sitosterol [2] . The signal for C-2 and C-4 in the spectrum of the acetate shift to upfield due to the β-effect of the acetoxy group. (Agrawal, 1992) . The signal for C-2 and C-4 in the spectrum of the glucoside shift to upfield, can also be ascribed to the β-effect of the glucoryl group. The location of the glucose at C-3 was further confirmed from the correlation of its H-1 1 at δ 4.12 with C-3 at δ 78.1 in HMBC (Heteronuclear Multiple-bond Correlation) and COSY (Correlation spectroscopy) experiments. Acid hydrolysis of [4] proved β-sitosterol to be the aglycone moiety (co-chromatography with reference sample) and glucose was the sugar moiety (using butanol-acetic acid-water ml, of isolated compounds in addition to different concentrations of standard antibiotics showed that friedelin [1] was able to reduce the MIC of norfloxacin from 32µg/ml to 16µg/ml (2-fold potentiation) against SA1199B. Friedelin also showed good modulation actions with erythromycin and tetracycline against RN4220 and XU212 respectively. Reserpine, which was used as control (Oluwatuyi et al., 2004) had 4-fold potentiation of tetracycline activity against XU212 and norfloxacin activity against SA1199B (Table 2 ). However, reserpine had no effect on erythromycin against RN4220 (MIC 256 µg/ml) whilst friedelin [1] showed a significant effect (16-fold potentiation).
RESULTS AND DISCUSSION
Triplicate experiments were carried out but each experiment gave the same MIC for a particular extract tested.
Different classes of compounds of plant origin have been found to possess bacterial resistance modulatory actions (Gibbons, 2005) . These include alkaloids (Brenwald et al., 1997) , flavonoids and coumarins (Tsutomu et al., 2005) , tannins and saponosides (Lee et al., 2000) , diterpenoids, triterpenoids and steroids (Silvia et al., 1999) .
Microbiological resistance mutations may be expressed in several ways. These include production of inactivating enzymes, changes in cell wall permeability, alterations to structural target, bypass of metabolic pathway, changes in efflux mechanisms and multiple resistance mechanisms (Wickens and Wade, 2005) . Efflux pumps occur naturally in bacterial cells and are concerned with the removal of waste products (Poole, 2005) . However, changes in their conformation can make them remove antimicrobials. Gram Positive organisms, including Staph. aureus can show resistance to tetracyclines by this mechanism (Miyamae et al., 2001) . However, it is common for organisms to exhibit resistance by using a combination of two or more of the above mechanisms. Macrolide resistance in Streptococci may be due to a combination of increased efflux and ribosomal modification, a scenario commonly referred to as multi-drug resistance (Di Perri and Bonora, 2004) .
In this study, the observed potentiation of the antimicrobial effects of the standard antibiotics used (tetracycline, erythromycin and norfloxacin) after combining them individually with 10 µg/ml of friedelin suggests it could modify the resistance mechanisms present. In the case of SA1199B, RN4220 and XU212 where the mechanisms of resistance have been confirmed to be by efflux (Gibbons, 2005) , friedelin in low concentrations may act as substrates for the efflux proteins which the resistant bacteria overexpress thus allowing the respective antibiotics to enter the bacterial cell to cause toxicity.
CONCLUSIONS
Friedelin, isolated from P. pinnata, has been found to be a bacterial resistance modulator. This interesting finding is of significance especially in a developing country like Ghana, where antibiotics are often abused and taken concurrently with herbal medications. This may mean that the concurrent use of herbal extracts (which may contain modulatory principles) and clinical antibiotics, even at normal therapeutic levels, should be done with caution since minute quantities of some herbal extracts may act synergistically with the antibiotics to cause toxicity to the individual recipient.
